Cargando…

IMPLEMENTATION OF AN EDUCATION INTERVENTION FOR MULTIPLE MYELOMA PATIENTS RECEIVING STEM CELL TRANSPLANT

Older adults have an increased risk for multiple myeloma (MM), yet they are often unable to collect sufficient healthy stem cells for autologous stem cell transplant (ASCT). We sought to assess the implementation of educational intervention videos, termed Ready for Transplant (R4T), for MM patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halpin, Sean, Konomos, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770288/ http://dx.doi.org/10.1093/geroni/igac059.933

Ejemplares similares

Interrupted Identities: Autologous Stem Cell Transplant in Patients With Multiple Myeloma
por: Halpin, Sean N, et al.
Publicado: (2021)

Becoming an Autologous Stem Cell Transplant Patient
por: Halpin, Sean, et al.
Publicado: (2020)

Using Conversation Analysis to Examine When Educational Videos Are Introduced in Patient Education
por: Halpin, Sean, et al.
Publicado: (2021)

Using Applied Conversation Analysis in Medical Education
por: Halpin, Sean, et al.
Publicado: (2020)

USING NATURALLY OCCURRING QUALITATIVE DATA IN GERONTOLOGICAL CANCER RESEARCH
por: Halpin, Sean, et al.
Publicado: (2022)

Talking about Complimentary and Alternative Medicine: A Conversation Analysis Study
por: Halpin, Sean, et al.
Publicado: (2021)

Using Applied Conversation Analysis in Patient Education
por: Halpin, Sean N., et al.
Publicado: (2021)

Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation
por: Xu, Jingyu, et al.
Publicado: (2023)

INTEGRATING DIVERSE CANCER PERSPECTIVES: FROM DEVELOPMENT TO IMPLEMENTATION
por: Halpin, Sean
Publicado: (2022)

Hematopoietic stem cell transplantation in Multiple Myeloma. Experience of the Instituto Nacional de Cancerologia, Mexico
por: Bahena-Garcia, Magdalena, et al.
Publicado: (2007)

Role of Stem Cell Transplantation in Multiple Myeloma
por: Devarakonda, Srinivas, et al.
Publicado: (2021)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Greil, Christine, et al.
Publicado: (2021)

Methodological Approaches to Transform, Develop, and Evaluate Cancer Care Interventions
por: Halpin, Sean
Publicado: (2021)

The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation
por: Tsai, Chun-Kuang, et al.
Publicado: (2021)

Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
por: Ailawadhi, Sikander, et al.
Publicado: (2022)

Multiple Myeloma
Publicado: (2019)

1593. Recurrence of Clostridium difficile Infection in Multiple Myeloma Patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole vs. No Prophylaxis
por: Moran, Gisele, et al.
Publicado: (2018)

Current status of autologous stem cell transplantation for multiple myeloma
por: Al Hamed, Rama, et al.
Publicado: (2019)

Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Claveau, Jean-Sébastien, et al.
Publicado: (2022)

Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients
por: FU, CHENGCHENG, et al.
Publicado: (2013)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
por: Malkan, Umit Yavuz, et al.
Publicado: (2021)

Experience of Autologous Stem Cell Transplant in Multiple Myeloma: The Patient and Caregiver Perspective
por: Hansen, Doris K, et al.
Publicado: (2023)

634. Implementation of a medical education intervention to improve acceptance of HIV-positive donors for transplant at a tertiary care hospital
por: Swaminathan, Neeraja, et al.
Publicado: (2022)

Respiratory Viral Infections in Multiple Myeloma Patients
por: Burgess, Mary J, et al.
Publicado: (2017)

2101. CMV Infections in Multiple Myeloma Patients
por: Ilyas, Sahrish, et al.
Publicado: (2022)

Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study: Treatment pattern and outcomes in patients with multiple myeloma
por: He, Jianming, et al.
Publicado: (2020)

Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation
por: Markovic, Uros, et al.
Publicado: (2022)

Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma
por: Biran, Noa, et al.
Publicado: (2021)

656. Cryptosporidiosis in Immunocompromised Patients with Cancer Receiving Chemotherapy, CAR-T Cell Therapy and Hematopoietic Stem Cell Transplantation: A Retrospective Analysis
por: Mann, Inderjit, et al.
Publicado: (2023)

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab plus bortezomib/thalidomide/dexamethasone in the phase III CASSIOPEIA study
por: Hulin, Cyrille, et al.
Publicado: (2021)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
por: Bergantim, Rui, et al.
Publicado: (2012)

Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017)

Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation
por: Al-Anazi, Khalid Ahmed
Publicado: (2012)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
por: Tosi, P., et al.
Publicado: (2012)

Complete response after autologous stem cell transplant in multiple myeloma
por: Kumar, Lalit, et al.
Publicado: (2014)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
por: Al-Mansour, Zeina, et al.
Publicado: (2014)

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma
por: Paquin, Ashley, et al.
Publicado: (2020)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
por: Yarlagadda, Lakshmi, et al.
Publicado: (2021)

Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi Arabia
por: Abdrabou, Ahmed Kotb, et al.
Publicado: (2021)

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
por: Srour, Samer A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fossd0o71orjavh67nnb0sbqn